Примери за използване на Combination with lenalidomide на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The geometric mean total clearance of elotuzumab at 10 mg/kg(in combination with lenalidomide and dexamethasone) at steady state is 0.194 L/day(CV: 62.9%).
When Empliciti is given in combination with lenalidomide or pomalidomide, you must follow the pregnancy prevention programme for lenalidomide
In combination with lenalidomide and dexamethasone or with bortezomib,
evaluated the pharmacokinetics of elotuzumab in combination with lenalidomide and dexamethasone in patients with multiple myeloma with varying degrees of renal impairment(classified using the CrCl values).
safety of Empliciti in combination with lenalidomide and dexamethasone in patients with multiple myeloma who have received one to three prior therapies.
safety of Empliciti in combination with lenalidomide and dexamethasone(E-Ld) in patients with multiple myeloma who have received one to three prior therapies.
Upon discontinuation of elotuzumab in combination with lenalidomide and dexamethasone, concentrations of elotuzumab will decrease to approximately 3%(approximately 97% washout as estimated by 5 half-lives)
Treatment with ixazomib in combination with lenalidomide and dexamethasone for longer than 24 cycles should be based on an individual benefit risk assessment,
compared treatment with DARZALEX 16 mg/kg in combination with lenalidomide and low-dose dexamethasone(DRd)
The safety data of elotuzumab have been assessed from a total of 554 patients with multiple myeloma treated with elotuzumab in combination with lenalidomide and dexamethasone(451 patients) or bortezomib and dexamethasone(103 patients) pooled across 6 clinical trials.
The efficacy and safety of ixazomib in combination with lenalidomide and dexamethasone was evaluated in an international randomised,
Upon discontinuation of elotuzumab in combination with lenalidomide and dexamethasone or in combination with pomalidomide
The safety data of elotuzumab have been assessed from a total of 682 patients with multiple myeloma treated with elotuzumab in combination with lenalidomide and dexamethasone(451 patients),
compared treatment with DARZALEX 16 mg/kg in combination with lenalidomide and low-dose dexamethasone(DRd)
Combination treatment with lenalidomide.
Combination dosing with lenalidomide and dexamethasone did not affect proteasome inhibition.
Combination treatment with lenalidomide and dexamethasone in patients ineligible for autologous stem cell transplant.
Lenalidomide in combination with dexamethasone in patients who are not eligible for stem cell transplantation.
Newly diagnosed multiple myeloma: patients who are not eligible for transplant treated with lenalidomide in combination with low dose dexamethasone.
Lenalidomide in combination with dexamethasone until disease progression in patients who are not eligible for transplant.